15931-19-8 Usage
Uses
Used in Pharmaceutical Industry:
2-methylpyridine-3,4-diamine is used as a building block for the synthesis of various organic compounds, particularly in the development of pharmaceuticals. Its unique structure allows for the creation of new molecules with potential therapeutic properties.
Used in Chemical Industry:
In the chemical industry, 2-methylpyridine-3,4-diamine is utilized as a precursor in the synthesis of a range of organic compounds. Its presence of amino groups at specific positions on the pyridine ring makes it a versatile intermediate for further chemical reactions and modifications.
Used in Medicinal Chemistry Research:
2-methylpyridine-3,4-diamine is used as a subject of study in medicinal chemistry to explore its potential biological activities. 2-methylpyridine-3,4-diamine's structure may offer insights into the development of new drugs or therapeutic agents, particularly if it exhibits specific binding affinities or interactions with biological targets.
Used in Safety and Hazard Assessment:
2-methylpyridine-3,4-diamine's potential hazards and safety precautions are considered in research and industrial applications to ensure the safe handling and use of 2-methylpyridine-3,4-diamine. This includes understanding its reactivity, toxicity, and other properties that may affect its application and the health of those who work with it.
Check Digit Verification of cas no
The CAS Registry Mumber 15931-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,3 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 15931-19:
(7*1)+(6*5)+(5*9)+(4*3)+(3*1)+(2*1)+(1*9)=108
108 % 10 = 8
So 15931-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H9N3/c1-4-6(8)5(7)2-3-9-4/h2-3H,8H2,1H3,(H2,7,9)
15931-19-8Relevant academic research and scientific papers
5-SUBSTITUTED IMIDAZO[4,5-C]PYRIDINES
-
, (2008/06/13)
The present invention relates to a class of compounds represented by the formula STR1 or a pharmaceutically acceptable salt thereof useful in the treatment of diseases or disorders mediated by platelet activating factor (PAF).
